The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How well is interdependent care managed across specialties in breast cancer? Metrics and pre-implementation data from the 4R in Oncology Project.
 
Christine B. Weldon
Consulting or Advisory Role - Genentech (Inst)
 
Julia Rachel Trosman
Consulting or Advisory Role - Foundation Medicine (Inst); Genentech (Inst)
 
Claudia B. Perez
No Relationships to Disclose
 
Swati Kulkarni
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer
 
Seema Ahsan Khan
Research Funding - Repros Therapeutics
 
Nora Hansen
Honoraria - Genentech/Roche
Speakers' Bureau - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Valerie Nelson
Consulting or Advisory Role - bioTheranostics
 
Jennifer Stein
No Relationships to Disclose
 
Melissa A. Simon
No Relationships to Disclose
 
Jonathan Blake Strauss
Consulting or Advisory Role - AIM Specialty Health
 
Al Bowen Benson
Consulting or Advisory Role - Alchemia; Astellas Pharma; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; Guardant Health; Guerbet; Helsinn Healthcare; Infinity Pharmaceuticals; IntegraGen; Lexicon; Lilly/ImClone; Merck Serono; Merck/Schering Plough; National Cancer Institute; Novartis; Opsona Therapeutics; Pharmacyclics; Precision Therapeutics; Sanofi; Spectrum Pharmaceuticals; Taiho Pharmaceutical; Vicus Therapeutics
Research Funding - advanced accelerator applications (Inst); Alchemia (Inst); Amgen (Inst); Astellas Pharma (Inst); AVEO (Inst); Bayer/Onyx (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AVEO; Bayer; Boehringer Ingelheim; Boston Biomedical; Dava Oncology; Genentech/Roche; Gilead Sciences; Guardant Health; guerbet; Helsinn Healthcare; Lilly/ImClone; Sanofi; Spectrum Pharmaceuticals; TRM Oncology
 
Sasa M. Espino
No Relationships to Disclose
 
Mikele Bunce
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Research Funding - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Wayne Pan
Employment - Genentech
Leadership - Semler Scientific
Stock and Other Ownership Interests - Genentech; Pfizer
 
Sarah M. Friedewald
Consulting or Advisory Role - Bard Medical
Research Funding - Hologic
 
William John Gradishar
No Relationships to Disclose